- Home
- FOXA vs ROIV Comparison
FOXA vs ROIV Comparison
Compare FOXA & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOXA | ROIV |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United Kingdom |
| Employees | 10400 | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.0B | 20.7B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | FOXA | ROIV |
|---|---|---|
| Price | $58.39 | $27.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 8 |
| Target Price | ★ $72.14 | $27.56 |
| AVG Volume (30 Days) | 3.4M | ★ 4.4M |
| Earning Date | 05-11-2026 | 02-06-2026 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $29,053,000.00 |
| Revenue This Year | $1.98 | N/A |
| Revenue Next Year | $4.37 | $594.84 |
| P/E Ratio | $13.70 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $46.42 | $8.73 |
| 52 Week High | $76.39 | $30.33 |
Technical Indicators
Market Signals| Indicator | FOXA | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 46.31 | 48.24 |
| Support Level | $56.10 | $26.94 |
| Resistance Level | $59.53 | $27.94 |
| Average True Range (ATR) | 1.67 | 0.89 |
| MACD | 0.45 | -0.38 |
| Stochastic Oscillator | 46.99 | 20.19 |
Price Performance
Historical ComparisonAbout FOXA Fox Corporation
Fox operates in two segments: cable networks and television. Cable networks primarily includes Fox News, Fox Business, and several pay TV sports stations. Television primarily includes the Fox broadcast network, 29 owned and operated local television stations, of which 18 are affiliated with the Fox network, and streaming platform Tubi, which is not subscription-based and is completely ad-supported. Fox effectively sold most of its entertainment assets to Disney in 2019, so it no longer creates entertainment content and relies heavily on live news and sports, with nearly all tied to the pay TV bundle. The Murdoch family controls Fox.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.